Endocrine Society has been an active leader on Capitol Hill advocating for diabetes prevention, coverage, and research programs. Here are some highlights of our recent activities: On October 5, the Society hosted a virtual congressional briefing focused on how the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) addresses racial and ethnic disparities. The...
The 8th Annual Meeting of EndoBridge® was held between 22-24 October 2020 as a virtual event due to ongoing concerns regarding COVID-19 pandemic. As usual, the three-day scientific program, accredited by the European Council, included state of the art lectures and interactive expert discussion panels on challenging and interesting clinical cases. Simultaneous translation into Russian,...
As Congress was not able to come to an agreement on the appropriations bills to fund the federal government for the next fiscal year (FY) in advance of the September 31 deadline, policy makers instead passed a Continuing Resolution that essentially funds the government at the prior year levels through December 11 2020. While it...
Patients with COVID-19 and vertebral fractures are twice as likely to die from the virus, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Andrea Giustina, MD, Director of the Institute of Endocrine and Metabolic Sciences of the San Raffaele Vita-Salute University and IRCCS San Raffaele Hospital in Milano, Italy, point out that osteoporosis is one...
Endocrine Society members Rexford Ahima, MD, PhD, Myles Brown, MD, Nancy Carrasco, MD, Mark Evers, MD, and Joel Hirschhorn, MD, PhD, have been elected to the National Academy of Medicine (NAM). They are five of the 90 regular members and 10 international members who were announced on October 19 at NAM’s annual meeting. Election to...
The COVID-19 pandemic has jumpstarted innovation in healthcare delivery and allowed for real-world testing of diabetes care models in unprecedented ways, according to a manuscript published in The Journal of Clinical Endocrinology & Metabolism. For diabetes, which affects half a billion people worldwide, innovation has long been overdue. Currently, less than 50% of people with...
The Endocrine Society welcomed the European Commission’s new Chemical Strategy for Sustainability and its measures to protect the public from endocrine-disrupting chemicals. The communication was released Wednesday as part of the European Green Deal. The strategy is designed to be the foundation for the biggest update to Europe’s chemical regulations in more than a decade. The chemical strategy commits to a hazard identification for endocrine-disrupting chemicals (EDCs), including strict measures to prevent them from being used in consumer products. In...
As childhood obesity becomes an “epidemic within an epidemic,” new guidance from the American Academy of Pediatrics echoes Endocrine Society recommendations on bariatric surgery for severely obese young people. Aside from reducing their weight, these procedures could benefit young people well into adulthood. Improved access to bariatric surgery is “urgently needed” for the severely obese...
The 8th Annual Meeting of EndoBridge® was held between 22-24 October 2020 as a virtual event due to ongoing concerns regarding COVID-19 pandemic. As usual, the three-day scientific program, accredited by the European Council, included state of the art lectures and interactive expert discussion panels on challenging and interesting clinical cases. Simultaneous translation into Russian,...